Publication

QKI Binds MAP1B mRNA and Enhances MAP1B Expression during Oligodendrocyte Development

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Lixia Zhao, Emory UniversityLi Ku, Emory UniversityYuntao Chen, Emory UniversityMingjing Xia, Emory UniversityPatrizia LoPresti, Northwestern UniversityYue Feng, Emory University
Language
  • English
Date
  • 2006-10
Publisher
  • American Society for Cell Biology
Publication Version
Copyright Statement
  • © 2006 by The American Society for Cell Biology
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1059-1524
Volume
  • 17
Issue
  • 10
Start Page
  • 4179
End Page
  • 4186
Grant/Funding Information
  • This work is supported by National Institutes of Health Grant NS39551 and National Multiple Sclerosis Society (NMSS) Grant RG 3296 to Y.F. and NMSS Grant PP0864 to P.L.
Abstract
  • Microtubule-associated protein 1B (MAP1B) is essential for neural development. Besides the abundant expression in neurons, MAP1B recently was found in myelinating oligodendroglia. Moreover, MAP1B deficiency causes delayed myelin development, suggesting the functional importance of MAP1B in oligodendroglia. However, molecular mechanisms that control MAP1B expression in oligodendroglia remain elusive. We report here that MAP1B mRNA is markedly up-regulated in the oligodendroglia cell line CG4 upon induced differentiation, leading to elevated MAP1B protein production. A coordinated regulation of homeoprotein transcription factors was observed during CG4 cell differentiation, which recapitulates the regulation in neurons that promotes MAP1B transcription. Hence, transcriptional regulation of MAP1B appears to be a common mechanism in both neurons and oligodendroglia. In addition, we found posttranscriptional regulation of MAP1B mRNA by the selective RNA-binding protein QKI in oligodendroglia. The 3′UTR of MAP1B mRNA interacts with QKI, and oligodendroglia-specific QKI-deficiency in the quakingviable mutant mice resulted in reduced MAP1B mRNA expression. Moreover, RNAi-mediated QKI-knockdown caused destabilization of the MAP1B mRNA in CG4 cells. Furthermore, forced expression of exogenous QKI was sufficient for promoting MAP1B expression. Because QKI is absent in neurons, QKI-dependent stabilization of MAP1B mRNA provides a novel mechanism for advancing MAP1B expression specifically in oligodendroglia during brain development.
Author Notes
Research Categories
  • Biology, Cell
  • Biology, Neuroscience
  • Health Sciences, Pharmacology

Tools

Relations

In Collection:

Items